Fresenius Medical Care AG & Co. KGaA (FMS) Financials

$21.70 +0.06 (+0.25%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$21.66 -0.04 (-0.18%)

As of 05/22/2026 04:40 PM Eastern

Annual Income Statements for Fresenius Medical Care AG & Co. KGaA

This table shows Fresenius Medical Care AG & Co. KGaA's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	1,315	1,203	1,537	2,268	1,346	1,422	1,097	720	810	767	1,398
Consolidated Net Income / (Loss)	1,315	1,494	1,867	2,547	1,614	1,754	1,380	957	810	767	1,398
Net Income / (Loss) Continuing Operations	1,315	1,223	1,867	2,547	1,614	1,754	1,380	957	810	767	1,398
Total Pre-Tax Income	1,929	2,152	2,400	3,132	2,065	2,366	1,779	1,304	1,143	1,094	1,775
Total Operating Income	2,282	2,534	2,726	2,467	2,547	2,815	2,096	1,388	-413	-1,016	-960
Total Gross Profit	5,625	5,908	7,229	5,900	6,056	6,765	5,402	4,436	4,225	3,393	3,631
Total Revenue	16,792	17,431	21,362	18,938	19,613	21,817	19,941	20,752	20,297	18,484	20,764
Operating Revenue	16,792	17,431	21,362	18,938	19,613	21,817	19,941	20,752	20,297	18,484	20,764
Total Cost of Revenue	11,167	11,523	14,133	13,038	13,558	15,052	14,539	16,316	16,072	15,091	17,133
Operating Cost of Revenue	11,167	11,523	14,133	13,038	-	-	-	16,316	16,072	15,091	17,133
Total Operating Expenses	3,343	3,450	4,503	3,433	3,591	4,065	4,053	3,048	4,638	4,409	4,590
Selling, General & Admin Expense	3,204	3,296	4,370	3,302	3,403	3,828	3,803	3,392	3,536	3,253	3,559
Research & Development Expense	139	154	133	131	189	237	250	245	257	190	185
Other Operating Expenses / (Income)	-	-	-	-	-	-	-	-588	845	966	846
Total Other Income / (Expense), net	-353	-577	-327	665	-399	-334	430	-83	1,555	2,110	2,735
Interest Expense	498	-	500	513	-	-	-	385	470	421	451
Interest & Investment Income	114	-67	62	169	69	51	83	72	98	74	82
Other Income / (Expense), net	31	-511	112	1,010	-468	-385	347	230	1,927	2,457	3,104
Income Tax Expense	614	658	532	585	451	611	399	348	332	327	377
Weighted Average Basic Shares Outstanding	305.31M	306.22M	306.45M	298.33M	298.33M	292.88M	293.00M	293.41M	293.41M	293.41M	279.29M
Weighted Average Diluted Shares Outstanding	305.31M	306.22M	306.45M	298.33M	298.33M	292.88M	293.00M	293.41M	293.41M	293.41M	279.29M
Weighted Average Basic & Diluted Shares Outstanding	305.31M	306.22M	306.45M	298.33M	298.33M	292.88M	293.00M	293.41M	293.41M	293.41M	279.29M

No quarterly income statements for Fresenius Medical Care AG & Co. KGaA are available.

This table details how cash moves in and out of Fresenius Medical Care AG & Co. KGaA's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	2,387	4,864	2,366	1,336	-1,277	3,860	2,981	1,886	1,625	2,162	1,795
Net Cash From Operating Activities	2,708	2,831	2,795	2,360	3,786	5,208	2,428	2,060	2,174	2,170	2,474
Net Cash From Continuing Operating Activities	2,708	2,831	2,795	2,629	3,786	5,208	2,428	2,060	2,174	2,170	2,474
Net Income / (Loss) Continuing Operations	1,315	1,494	1,867	2,547	1,614	1,754	1,380	957	810	767	1,398
Consolidated Net Income / (Loss)	1,315	1,494	1,867	2,547	1,614	1,754	1,380	957	810	767	1,398
Depreciation Expense	704	738	883	904	1,788	2,182	1,838	1,967	1,938	1,803	1,761
Non-Cash Adjustments To Reconcile Net Income	-150	234	21	-657	768	-562	-432	-446	-571	-534	-635
Changes in Operating Assets and Liabilities, net	838	365	23	-165	-384	1,834	-358	-417	-3.06	134	-49
Net Cash From Investing Activities	-310	549	-680	280	-4,447	-1,601	-1,458	-773	-606	-96	-863
Net Cash From Continuing Investing Activities	-310	549	-680	-315	-4,447	-1,601	-1,458	-773	-606	-96	-863
Purchase of Property, Plant & Equipment	-	-	-	-	-1,262	-1,285	-967	-775	-757	-724	-1,074
Acquisitions	-310	549	-680	-	-2,493	-316	-491	-63	-39	-24	-26
Divestitures	-	-	-	-	49	-	-	64	190	652	237
Net Cash From Financing Activities	-12	1,484	251	780	-274	254	2,012	599	57	88	184
Net Cash From Continuing Financing Activities	-12	1,484	251	-1,153	-274	254	2,012	599	57	88	184
Repayment of Debt	-351	506	-429	-1,232	-3,898	-717	-30	-168	-16	0.00	0.00
Issuance of Debt	339	978	680	701	5,027	971	2,042	767	72	88	184
Cash Interest Received	81	47	45	-	55	51	83	72	98	70	80

No quarterly cash flow statements for Fresenius Medical Care AG & Co. KGaA are available.

This table presents Fresenius Medical Care AG & Co. KGaA's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	25,365	26,830	28,860	30,035	36,961	38,711	38,896	38,250	37,533	34,745	36,384
Total Current Assets	6,768	7,242	7,657	8,981	8,041	8,888	9,017	7,793	7,986	6,890	8,115
Cash & Equivalents	550	746	1,175	2,456	1,131	1,321	1,677	1,363	1,553	1,222	1,877
Accounts Receivable	3,503	3,893	4,206	3,926	4,018	3,963	4,042	3,974	4,023	3,528	3,726
Inventories, net	1,341	1,407	1,551	1,679	1,867	2,315	2,307	2,456	2,411	2,141	2,512
Plant, Property, & Equipment, net	3,426	3,766	4,194	4,390	4,703	4,956	4,793	4,443	4,185	3,774	4,092
Plant, Property & Equipment, gross	-	3,766	4,194	4,390	4,703	4,956	4,793	4,443	4,185	3,774	4,092
Total Noncurrent Assets	15,171	15,822	17,009	16,663	24,218	24,868	25,086	26,014	25,363	24,081	24,178
Long-Term Investments	645	629	777	744	782	930	891	828	711	643	779
Goodwill	13,033	13,629	14,540	13,974	15,731	15,830	16,254	16,893	16,206	15,703	15,927
Intangible Assets	830	845	821	780	1,601	1,687	1,652	1,625	1,507	1,418	1,472
Noncurrent Deferred & Refundable Income Taxes	189	307	379	396	405	429	357	335	314	238	278
Other Noncurrent Operating Assets	474	412	492	770	5,698	5,992	5,932	6,334	6,063	5,913	5,717
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	0.00	562	167	4.22
Total Liabilities & Shareholders' Equity	25,365	26,830	28,860	30,035	36,961	38,711	38,896	38,250	37,533	34,745	36,384
Total Liabilities	13,841	15,204	15,853	15,268	22,117	23,647	23,075	21,722	21,132	18,423	19,622
Total Current Liabilities	4,149	4,683	5,244	6,019	5,467	5,278	6,553	5,301	5,127	4,424	4,607
Short-Term Debt	793	605	924	1,596	1,315	97	1,421	694	505	2.17	20
Accounts Payable	781	883	886	910	937	1,011	971	1,018	979	1,019	981
Other Current Liabilities	-	3,195	3,434	3,324	3,214	4,170	4,161	3,589	3,643	3,403	3,606
Total Noncurrent Liabilities	9,691	10,521	10,608	9,249	16,650	18,370	16,521	16,421	16,005	13,999	15,015
Long-Term Debt	7,853	7,950	8,022	7,041	8,872	9,539	8,279	8,414	8,238	7,076	8,553
Capital Lease Obligations	-	-	-	0.00	5,280	5,488	5,375	5,005	4,586	4,286	4,097
Noncurrent Deferred & Payable Income Tax Liabilities	625	950	742	717	1,032	1,201	1,180	1,185	1,086	961	1,101
Noncurrent Employee Benefit Liabilities	585	539	637	632	773	878	886	550	735	702	675
Other Noncurrent Operating Liabilities	466	1,081	1,207	859	692	1,264	801	1,267	1,160	945	590
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	0.00	200	28	0.00
Total Equity & Noncontrolling Interests	10,496	11,626	13,269	14,766	17,175	15,064	15,821	16,528	16,401	16,322	16,762
Total Preferred & Common Equity	9,887	10,496	12,058	13,458	15,751	13,700	14,372	14,966	15,067	15,088	15,620
Total Common Equity	10,897	10,496	12,058	13,458	15,751	13,700	14,372	14,966	15,067	15,088	15,620
Common Stock	3,857	4,489	5,138	4,785	4,390	3,867	3,604	3,922	4,064	3,767	3,958
Retained Earnings	7,871	6,402	8,574	10,108	10,611	12,527	12,253	11,459	12,082	11,662	14,327
Treasury Stock	505	-54	131	-58	-416	-	-	-	-	0.00	-688
Accumulated Other Comprehensive Income / (Loss)	-1,336	-341	-1,785	-1,378	1,166	-2,694	-1,485	-416	-1,079	-340	-1,977
Noncontrolling Interest	609	1,129	1,211	1,309	1,425	1,364	1,449	1,562	1,334	1,234	1,142

No quarterly balance sheets for Fresenius Medical Care AG & Co. KGaA are available.

This table displays calculated financial ratios and metrics derived from Fresenius Medical Care AG & Co. KGaA's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.08%	3.80%	22.55%	-11.35%	3.57%	11.23%	-8.60%	4.07%	3.70%	-6.99%	12.34%
EBITDA Growth	2.14%	-8.47%	34.76%	17.71%	-11.73%	19.26%	-7.17%	-16.28%	2.90%	1.68%	20.35%
EBIT Growth	2.58%	-12.51%	40.25%	22.51%	-40.21%	16.89%	0.55%	-33.80%	8.20%	11.23%	48.77%
NOPAT Growth	0.97%	13.08%	20.59%	-5.43%	-0.75%	4.83%	-22.11%	-37.40%	5.54%	-5.94%	-6.14%
Net Income Growth	4.41%	13.57%	25.00%	36.41%	-36.62%	8.65%	-21.34%	-30.66%	-15.31%	-5.35%	82.31%
EPS Growth	0.00%	19.17%	11.53%	55.05%	-38.60%	0.00%	-16.41%	-25.66%	-23.57%	0.73%	0.00%
Operating Cash Flow Growth	45.51%	4.53%	-1.27%	-15.58%	60.45%	37.53%	-53.38%	-15.13%	5.52%	-0.20%	14.04%
Free Cash Flow Firm Growth	701.26%	21.55%	-52.03%	94.90%	-443.88%	141.10%	-51.66%	-27.22%	169.58%	0.57%	-359.90%
Invested Capital Growth	-0.17%	-0.90%	6.36%	1.01%	40.56%	-1.63%	1.41%	0.43%	-4.73%	-5.25%	4.24%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.50%	33.89%	33.84%	31.15%	30.87%	31.01%	27.09%	21.37%	25.32%	24.60%	17.49%
EBITDA Margin	17.97%	15.84%	17.42%	23.13%	19.71%	21.14%	21.47%	17.27%	17.14%	18.74%	18.81%
Operating Margin	13.59%	14.54%	12.76%	13.03%	12.99%	12.90%	10.51%	6.69%	7.04%	7.20%	-4.62%
EBIT Margin	13.77%	11.61%	13.28%	18.36%	10.60%	11.14%	12.25%	7.79%	8.13%	9.72%	10.33%
Profit (Net Income) Margin	7.83%	8.57%	8.74%	13.45%	8.23%	8.04%	6.92%	4.61%	3.77%	3.83%	6.73%
Tax Burden Percent	68.18%	69.42%	77.82%	81.33%	78.17%	74.15%	77.55%	73.35%	70.90%	70.10%	78.78%
Interest Burden Percent	83.42%	106.34%	84.56%	90.09%	99.35%	97.36%	72.82%	80.65%	65.31%	56.21%	82.77%
Effective Tax Rate	31.82%	30.58%	22.18%	18.67%	21.83%	25.85%	22.45%	26.65%	29.10%	29.90%	21.22%
Return on Invested Capital (ROIC)	8.19%	9.31%	10.93%	9.98%	8.19%	7.41%	5.78%	3.58%	3.87%	3.83%	-2.88%
ROIC Less NNEP Spread (ROIC-NNEP)	5.44%	5.92%	7.28%	18.87%	3.67%	4.64%	3.84%	3.09%	1.53%	1.40%	19.36%
Return on Net Nonoperating Assets (RNNOA)	4.63%	4.19%	4.07%	8.19%	1.91%	3.47%	3.16%	2.33%	1.05%	0.86%	11.33%
Return on Equity (ROE)	12.82%	13.51%	15.00%	18.17%	10.11%	10.88%	8.93%	5.92%	4.92%	4.69%	8.45%
Cash Return on Invested Capital (CROIC)	8.36%	10.22%	4.77%	8.97%	-25.53%	9.05%	4.38%	3.16%	8.71%	9.22%	-7.03%
Operating Return on Assets (OROA)	9.11%	7.75%	10.19%	11.81%	6.21%	6.42%	6.30%	4.19%	4.62%	5.39%	6.03%
Return on Assets (ROA)	5.18%	5.72%	6.71%	8.65%	4.82%	4.64%	3.56%	2.48%	2.14%	2.12%	3.93%
Return on Common Equity (ROCE)	13.33%	13.06%	13.59%	16.54%	9.24%	9.94%	8.12%	5.36%	4.49%	4.32%	7.84%
Return on Equity Simple (ROE_SIMPLE)	13.30%	14.23%	15.49%	18.93%	10.25%	12.80%	9.60%	6.39%	5.38%	5.08%	0.00%
Net Operating Profit after Tax (NOPAT)	1,556	1,759	2,122	2,006	1,991	2,087	1,626	1,018	1,074	1,010	-756
NOPAT Margin	9.26%	10.09%	9.93%	10.59%	10.15%	9.57%	8.15%	4.90%	4.99%	5.05%	-3.64%
Net Nonoperating Expense Percent (NNEP)	2.75%	3.39%	3.65%	-8.89%	4.52%	2.77%	1.94%	0.50%	2.33%	2.43%	-22.24%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	3.32%	3.61%	3.65%	-2.57%
Cost of Revenue to Revenue	66.50%	66.11%	66.16%	68.85%	69.13%	68.99%	72.91%	78.63%	74.68%	75.40%	82.51%
SG&A Expenses to Revenue	19.08%	18.91%	20.46%	17.44%	17.35%	17.55%	19.07%	16.34%	20.36%	21.08%	17.14%
R&D to Revenue	0.83%	0.88%	0.62%	0.69%	0.96%	1.09%	1.25%	1.18%	1.19%	0.95%	0.89%
Operating Expenses to Revenue	19.91%	19.79%	21.08%	18.13%	18.31%	18.63%	20.32%	14.69%	21.55%	22.03%	22.11%
Earnings before Interest and Taxes (EBIT)	2,313	2,023	2,838	3,477	2,079	2,430	2,443	1,617	1,750	1,946	2,144
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,017	2,761	3,721	4,380	3,867	4,611	4,281	3,584	3,688	3,750	3,905
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.65	0.64	0.82	0.61	0.30	0.39	0.44	0.45
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.46	0.51	0.51	0.44	0.22	0.28	0.33	0.34
Price to Earnings (P/E)	0.00	0.00	0.00	3.83	7.48	7.90	8.01	6.29	10.76	11.93	5.00
Dividend Yield	1.22%	1.25%	1.17%	2.19%	1.99%	1.90%	5.12%	9.87%	2.99%	2.84%	3.42%
Earnings Yield	0.00%	0.00%	0.00%	26.09%	13.37%	12.66%	12.49%	15.89%	9.29%	8.38%	20.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.76	0.88	0.91	0.80	0.63	0.68	0.68	0.68
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.82	1.28	1.17	1.14	0.87	0.85	0.87	0.87
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	3.53	6.48	5.52	5.31	5.03	4.97	4.63	4.65
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	4.44	12.05	10.48	9.31	11.14	10.48	8.93	8.46
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	7.70	12.58	12.20	13.99	17.70	17.07	17.20	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	6.54	6.61	4.89	9.37	8.75	8.44	8.01	7.33
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	8.56	0.00	9.99	18.45	20.08	7.58	7.14	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.82	0.74	0.67	0.58	0.90	1.00	0.95	0.85	0.81	0.70	0.76
Long-Term Debt to Equity	0.75	0.68	0.60	0.48	0.82	1.00	0.86	0.81	0.78	0.70	0.75
Financial Leverage	0.85	0.71	0.56	0.43	0.52	0.75	0.82	0.76	0.69	0.61	0.59
Leverage Ratio	2.47	2.36	2.24	2.10	2.10	2.35	2.51	2.38	2.30	2.21	2.15
Compound Leverage Factor	2.06	2.51	1.89	1.89	2.08	2.29	1.83	1.92	1.50	1.24	1.78
Debt to Total Capital	45.17%	42.39%	40.27%	36.90%	47.38%	50.10%	48.79%	46.06%	44.84%	41.05%	43.05%
Short-Term Debt to Total Capital	4.14%	3.00%	4.16%	6.82%	4.03%	0.32%	4.60%	2.27%	1.70%	0.01%	0.07%
Long-Term Debt to Total Capital	41.03%	39.39%	36.11%	30.09%	43.36%	49.78%	44.19%	43.80%	43.14%	41.04%	42.98%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.18%	5.60%	5.45%	5.59%	4.36%	4.52%	4.69%	5.10%	4.49%	4.46%	3.88%
Common Equity to Total Capital	56.93%	52.01%	54.28%	57.50%	48.25%	45.38%	46.52%	48.84%	50.68%	54.50%	53.07%
Debt to EBITDA	2.87	3.10	2.40	1.97	4.00	3.28	3.52	3.94	3.61	3.03	3.24
Net Debt to EBITDA	2.47	2.60	1.88	1.24	3.51	2.79	2.92	3.33	3.00	2.53	2.56
Long-Term Debt to EBITDA	2.60	2.88	2.16	1.61	3.66	3.26	3.19	3.74	3.48	3.03	3.24
Debt to NOPAT	5.56	4.86	4.22	4.30	7.77	7.25	9.27	13.87	12.41	11.25	-16.76
Net Debt to NOPAT	4.79	4.08	3.30	2.71	6.81	6.17	7.69	11.72	10.30	9.40	-13.25
Long-Term Debt to NOPAT	5.05	4.52	3.78	3.51	7.11	7.20	8.40	13.19	11.94	11.25	-16.73
Altman Z-Score	0.00	0.00	0.00	1.94	1.47	1.62	1.47	1.30	1.44	1.53	1.65
Noncontrolling Interest Sharing Ratio	-4.03%	3.29%	9.40%	8.99%	8.56%	8.65%	9.11%	9.31%	8.79%	7.85%	7.18%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.63	1.55	1.46	1.49	1.47	1.68	1.38	1.47	1.56	1.56	1.76
Quick Ratio	0.98	0.99	1.03	1.06	0.94	1.00	0.87	1.01	1.09	1.07	1.22
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,588	1,930	926	1,804	-6,204	2,550	1,233	897	2,419	2,432	-1,844
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	303.07%	405.22%	251.06%	266.01%	287.08%	299.72%	230.33%
Free Cash Flow to Firm to Interest Expense	3.19	0.00	1.85	3.51	0.00	0.00	0.00	2.33	0.00	0.00	-4.09
Operating Cash Flow to Interest Expense	5.44	0.00	5.59	4.60	0.00	0.00	0.00	5.35	0.00	0.00	5.48
Operating Cash Flow Less CapEx to Interest Expense	5.44	0.00	5.59	4.72	0.00	0.00	0.00	3.34	0.00	0.00	3.10
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.66	0.67	0.77	0.64	0.59	0.58	0.51	0.54	0.57	0.55	0.58
Accounts Receivable Turnover	4.87	4.71	5.28	4.66	4.94	5.47	4.98	5.18	5.38	5.30	5.72
Inventory Turnover	9.09	8.39	9.56	8.08	7.65	7.20	6.29	6.85	6.60	6.63	7.36
Fixed Asset Turnover	5.00	4.85	5.37	4.41	4.31	4.52	4.09	4.49	4.99	5.03	5.28
Accounts Payable Turnover	14.94	13.85	15.97	14.52	14.68	15.45	14.68	16.41	16.09	15.11	17.14
Days Sales Outstanding (DSO)	74.99	77.44	69.19	78.36	73.92	66.77	73.27	70.49	67.81	68.85	63.76
Days Inventory Outstanding (DIO)	40.14	43.52	38.19	45.20	47.72	50.70	58.02	53.28	55.27	55.04	49.56
Days Payable Outstanding (DPO)	24.43	26.36	22.85	25.14	24.87	23.62	24.87	22.24	22.68	24.16	21.30
Cash Conversion Cycle (CCC)	90.71	94.60	84.53	98.42	96.78	93.85	106.42	101.53	100.40	99.72	92.02
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	18,976	18,806	20,002	20,204	28,399	27,936	28,330	28,450	27,106	25,684	26,772
Invested Capital Turnover	0.88	0.92	1.10	0.94	0.81	0.77	0.71	0.73	0.77	0.76	0.79
Increase / (Decrease) in Invested Capital	-32	-171	1,196	202	8,195	-462	393	121	-1,344	-1,422	1,088
Enterprise Value (EV)	0.00	0.00	0.00	15,442	25,046	25,467	22,744	18,018	18,339	17,377	18,145
Market Capitalization	0.00	0.00	0.00	8,696	10,067	11,231	8,786	4,534	5,939	6,643	6,989
Book Value per Share	$35.69	$34.28	$39.35	$43.91	$51.33	$45.92	$49.05	$51.08	$51.35	$51.42	$53.24
Tangible Book Value per Share	($9.71)	($12.99)	($10.78)	($4.23)	($5.15)	($12.79)	($12.06)	($12.12)	($9.02)	($6.93)	($6.06)
Total Capital	19,142	20,181	22,216	23,403	32,643	30,187	30,897	30,641	29,731	27,686	29,432
Total Debt	8,646	8,555	8,946	8,637	15,467	15,123	15,076	14,113	13,330	11,364	12,670
Total Long-Term Debt	7,853	7,950	8,022	7,041	14,152	15,027	13,654	13,419	12,825	11,362	12,650
Net Debt	7,452	7,180	6,994	5,437	13,554	12,872	12,508	11,923	11,066	9,500	10,014
Capital Expenditures (CapEx)	0.00	0.00	0.00	-62	1,249	1,285	967	775	757	724	1,074
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,862	2,418	2,162	2,102	2,758	2,385	2,208	1,823	1,811	1,247	1,652
Debt-free Net Working Capital (DFNWC)	3,412	3,164	3,337	4,557	3,889	3,707	3,885	3,185	3,364	2,468	3,529
Net Working Capital (NWC)	2,619	2,559	2,413	2,962	2,574	3,610	2,464	2,491	2,859	2,466	3,509
Net Nonoperating Expense (NNE)	240	265	254	-541	377	333	246	61	264	243	-2,154
Net Nonoperating Obligations (NNO)	8,480	7,180	6,733	5,437	11,223	12,872	12,508	11,923	10,705	9,362	10,010
Total Depreciation and Amortization (D&A)	704	738	883	904	1,788	2,182	1,838	1,967	1,938	1,803	1,761
Debt-free, Cash-free Net Working Capital to Revenue	17.04%	13.87%	10.12%	11.10%	14.06%	10.93%	11.07%	8.78%	8.42%	6.23%	7.96%
Debt-free Net Working Capital to Revenue	20.32%	18.15%	15.62%	24.06%	19.83%	16.99%	19.48%	15.35%	15.63%	12.33%	16.99%
Net Working Capital to Revenue	15.60%	14.68%	11.29%	15.64%	13.13%	16.55%	12.36%	12.01%	13.28%	12.32%	16.90%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.38	$4.07	$4.17	$6.47	$3.96	$0.00	$3.31	$2.30	$1.70	$1.89	$0.00
Adjusted Weighted Average Basic Shares Outstanding	305.31M	306.22M	306.45M	306.88M	298.33M	0.00	293.00M	293.41M	293.41M	293.41M	279.29M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$4.16	$6.45	$3.96	$0.00	$3.31	$2.30	$1.70	$1.89	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	305.31M	306.22M	306.45M	306.88M	298.33M	0.00	293.00M	293.41M	293.41M	293.41M	279.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	305.31M	306.22M	306.45M	306.88M	298.33M	0.00	293.00M	293.41M	293.41M	293.41M	279.29M
Normalized Net Operating Profit after Tax (NOPAT)	1,556	1,759	2,122	2,006	1,991	2,087	1,626	1,018	1,074	1,010	-756
Normalized NOPAT Margin	9.26%	10.09%	9.93%	10.59%	10.15%	9.57%	8.15%	4.90%	4.99%	5.05%	-3.64%
Pre Tax Income Margin	11.49%	12.34%	11.23%	16.54%	10.53%	10.84%	8.92%	6.29%	5.31%	5.47%	8.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.65	0.00	5.68	6.77	0.00	0.00	0.00	4.20	0.00	0.00	4.75
NOPAT to Interest Expense	3.13	0.00	4.24	3.91	0.00	0.00	0.00	2.64	0.00	0.00	-1.68
EBIT Less CapEx to Interest Expense	4.65	0.00	5.68	6.90	0.00	0.00	0.00	2.19	0.00	0.00	2.37
NOPAT Less CapEx to Interest Expense	3.13	0.00	4.24	4.03	0.00	0.00	0.00	0.63	0.00	0.00	-4.06
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	14.60%	45.24%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	16.27%	86.94%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

No quarterly metrics and ratios for Fresenius Medical Care AG & Co. KGaA are available.

Financials Breakdown Chart

Fresenius Medical Care AG & Co. KGaA Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Fresenius Medical Care AG & Co. KGaA's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Fresenius Medical Care AG & Co. KGaA's net income appears to be on a downward trend, with a most recent value of $1.40 billion in 2025, rising from $1.32 billion in 2015. The previous period was $766.87 million in 2024. See where experts think Fresenius Medical Care AG & Co. KGaA is headed by visiting Fresenius Medical Care AG & Co. KGaA's forecast page.

Fresenius Medical Care AG & Co. KGaA's total operating income in 2025 was -$959.74 million, based on the following breakdown:

Total Gross Profit: $3.63 billion
Total Operating Expenses: $4.59 billion

Over the last 10 years, Fresenius Medical Care AG & Co. KGaA's total revenue changed from $16.79 billion in 2015 to $20.76 billion in 2025, a change of 23.6%.

Fresenius Medical Care AG & Co. KGaA's total liabilities were at $19.62 billion at the end of 2025, a 6.5% increase from 2024, and a 41.8% increase since 2015.

In the past 10 years, Fresenius Medical Care AG & Co. KGaA's cash and equivalents has ranged from $549.50 million in 2015 to $2.46 billion in 2018, and is currently $1.88 billion as of their latest financial filing in 2025.

Over the last 10 years, Fresenius Medical Care AG & Co. KGaA's book value per share changed from 35.69 in 2015 to 53.24 in 2025, a change of 49.2%.

Related Companies

Financial statements for NYSE:FMS last updated on 3/1/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fresenius Medical Care AG & Co. KGaA (FMS) Financials

Financials Breakdown Chart

Fresenius Medical Care AG & Co. KGaA Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fresenius Medical Care AG & Co. KGaA (FMS) Financials

Annual Income Statements for Fresenius Medical Care AG & Co. KGaA

Quarterly Income Statements for Fresenius Medical Care AG & Co. KGaA

Annual Cash Flow Statements for Fresenius Medical Care AG & Co. KGaA

Quarterly Cash Flow Statements for Fresenius Medical Care AG & Co. KGaA

Annual Balance Sheets for Fresenius Medical Care AG & Co. KGaA

Quarterly Balance Sheets for Fresenius Medical Care AG & Co. KGaA

Annual Metrics And Ratios for Fresenius Medical Care AG & Co. KGaA

Quarterly Metrics And Ratios for Fresenius Medical Care AG & Co. KGaA

Financials Breakdown Chart

Fresenius Medical Care AG & Co. KGaA Financials - Frequently Asked Questions

When does Fresenius Medical Care AG & Co. KGaA's financial year end?

How has Fresenius Medical Care AG & Co. KGaA's net income changed over the last 10 years?

What is Fresenius Medical Care AG & Co. KGaA's operating income?

How has Fresenius Medical Care AG & Co. KGaA's revenue changed over the last 10 years?

How much debt does Fresenius Medical Care AG & Co. KGaA have?

How much cash does Fresenius Medical Care AG & Co. KGaA have?

How has Fresenius Medical Care AG & Co. KGaA's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools